🇺🇸 FDA
Pipeline program

I004

API-I004-CL-C

Phase 3 small_molecule active

Quick answer

I004 for Pharmacokinetics is a Phase 3 program (small_molecule) at Amphastar Pharmaceuticals with 2 ClinicalTrials.gov record(s).

Program details

Company
Amphastar Pharmaceuticals
Indication
Pharmacokinetics
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials